SALIX PHARMACEUTICALS INC's ticker is SLXP and the CUSIP is 795435106. A total of 356 filers reported holding SALIX PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is 0.86 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $780,000 | -17.3% | 4,512 | -45.0% | 0.02% | -16.0% |
| Q4 2014 | $943,000 | -10.4% | 8,203 | +21.8% | 0.02% | -10.7% |
| Q3 2014 | $1,053,000 | +2.9% | 6,737 | -18.8% | 0.03% | +3.7% |
| Q2 2014 | $1,023,000 | +19.1% | 8,292 | 0.0% | 0.03% | +17.4% |
| Q1 2014 | $859,000 | +15.1% | 8,292 | 0.0% | 0.02% | +21.1% |
| Q4 2013 | $746,000 | +34.4% | 8,292 | 0.0% | 0.02% | +26.7% |
| Q3 2013 | $555,000 | – | 8,292 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 467,943 | $30,954,000 | 11.01% |
| TANG CAPITAL MANAGEMENT LLC | 300,000 | $19,845,000 | 7.82% |
| OAK RIDGE INVESTMENTS LLC | 1,382,895 | $91,478,000 | 2.87% |
| SECTOR GAMMA AS | 147,001 | $9,724,000 | 2.84% |
| Credo Capital Management, LLC | 38,869 | $2,571,000 | 1.98% |
| Cardinal Capital Management | 48,226 | $3,190,000 | 1.89% |
| ZEVENBERGEN CAPITAL INVESTMENTS LLC | 626,800 | $41,463,000 | 1.68% |
| HERNDON CAPITAL MANAGEMENT LLC | 1,284,472 | $84,967,823,000 | 1.27% |
| CATAPULT CAPITAL MANAGEMENT LLC | 45,000 | $2,977,000 | 1.24% |
| Pier Capital, LLC | 108,556 | $7,181,000 | 1.10% |